Evidence map›Paper›PMID 33107198›Full record

SynthesisCancer medicine2020

Safety and efficacy of photobiomodulation therapy in oncology: A systematic review.

René-Jean Bensadoun, Joel B Epstein, Raj G Nair, Andrei Barasch, Judith E Raber-Durlacher, Cesar Migliorati, Marie-Thérèse Genot-Klastersky, Nathaniel Treister, Praveen Arany, Joy Lodewijckx and 2 more

2 registry-linked trialsOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 47 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 5 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07183267 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Reducing rAdiation aDverse Effects of dermatitIs and mucosAl inflammatioN Using Red Light Therapy

TypeinterventionalSponsorThe Christie NHS Foundation TrustRan2026 to 2028Enrolled248ConditionsRadio Dermatitis, Mucositis Oral, OesophagitisArmsPhotobiomodulation
NCT07387978 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Pilot Study to Describe the Effect of Photobiomodulation in Reducing the Severity and Incidence of Oral Mucositis in Oral Cancer Patients Undergoing Radiation Treatment

TypeinterventionalSponsorPeter MacCallum Cancer Centre, AustraliaRan2025 to 2028Enrolled30ConditionsOral MucositisArmsphotobiomodulation
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 5 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. The supportive use of photobiomodulation on salivary glands: a narrative review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Trial
  10. Review
  11. Article
  12. Article
  13. Review
  14. Transcranial photobiomodulation for the treatment of chemobrain: new perspectives from a pilot study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Photobiomodulation therapy.JADA foundational science · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 5 countries.

René-Jean BensadounCentre de Haute Energie, Nice, France.ORCID 0000-0003-1290-7497
Joel B EpsteinCity of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Raj G NairOral Medicine/Oral Oncology, Griffith University and Haematology and Oncology, Gold Coast University Hospital, Queensland Health, Gold Coast, QLD, Australia.
Andrei BaraschHarvard School of Dental Medicine, Cambridge Health Alliance, Cambridge, MA, USA.
Judith E Raber-DurlacherDepartment of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Cesar MiglioratiCollege of Dentistry, Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida, Gainesville, FL, USA.
Marie-Thérèse Genot-KlasterskyInstitut Jules-Bordet, Brussels, Belgium.
Nathaniel TreisterDepartment of Oral Medicine, Harvard School of Dental Medicine, Boston, MA, USA.
Praveen AranySchool of Dental Medicine, University of Buffalo, Buffalo, NY, USA.
Joy LodewijckxFaculty of Medicine and Life Sciences, UHasselt, Hasselt, Belgium.
Jolien RobijnsFaculty of Medicine and Life Sciences, UHasselt, Hasselt, Belgium.ORCID 0000-0002-6286-1581
World Association for Laser Therapy (WALT)
Hasselt University · BEAcademic Center for Dentistry Amsterdam · NLCambridge Health Alliance · USCentre de Haute Energie · FRCity of Hope · USGriffith University · AUHarvard University · USInstitut Jules Bordet · BEUniversity at Buffalo, State University of New York · USUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed a systematic review of the current literature addressing the safety and efficacy of photobiomodulation therapy (PBMT) in cancer patients. In this systematic review, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used. In vitro, in vivo, and clinical studies, which investigated the effect of PBMT on cell proliferation/differentiation, tumor growth, recurrence rate, and/or overall survival were included. The Medline/PubMed, EMBASE, and Scopus databases were searched through April 2020. A total of 67 studies met the inclusion criteria with 43 in vitro, 15 in vivo, and 9 clinical studies identified. In vitro studies investigating the effect of PBMT on a diverse range of cancer cell lines demonstrated conflicting results. This could be due to the differences in used parameters and the frequency of PBM applications. In vivo studies and clinical trials with a follow-up period demonstrated that PBMT is safe with regards to tumor growth and patient advantage in the prevention and treatment of specific cancer therapy-related complications. Current human studies, supported by most animal studies, show safety with PBMT using currently recommended clinical parameters, including in Head & Neck cancer (HNC) in the area of PBMT exposure. A significant and growing literature indicates that PBMT is safe and effective, and may even offer a benefit in patient overall survival. Nevertheless, continuing research is indicated to improve understanding and provide further elucidation of remaining questions regarding PBM use in oncology.

Indexed as

Low-Level Light TherapyAnimalsCell DifferentiationCell ProliferationHumansNeoplasmsTreatment OutcomeTumor Burdencancerphotobiomodulationsafetysupportive caresystematic review

Identifiers

PMID33107198
PMCPMC7666741
OpenAlexW3094632787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.